Swedish pharmaceutical company Meda has agreed to buy Italian peer Rottapharm for $3.08 billion, as it looks to broaden its stable of products and expand its reach into emerging markets.
WSJ.com: What's News US, Wall Street Journal: Home US
Thu, 07/31/2014 - 12:17am
Swedish pharmaceutical company Meda has agreed to buy Italian peer Rottapharm for $3.08 billion, as it looks to broaden its stable of products and expand its reach into emerging markets.